Kolexia
Pommeret Fanny Oncologie médicale
Pommeret Fanny
Oncologie médicale
Gustave-Roussy
Villejuif, France
80 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Tumeurs de l'ovaire Carcinome épithélial de l'ovaire Post-Acute COVID-19 Syndrome Infections à coronavirus Tumeurs du sein Pneumopathie virale Récidive tumorale locale Tumeurs hématologiques

Collaborateurs

Voir plus
Colomba-Blameble Emeline
Colomba-Blameble Emeline
Chu De Martinique Site De Clarac, Fort-de-France, France
Barlesi Fabrice
Barlesi Fabrice
Gustave-Roussy, Villejuif, France
Michot Jean-Marie
Michot Jean-Marie
Gustave-Roussy, Villejuif, France
Albiges Laurence
Albiges Laurence
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Lilly
1 collaboration(s)
Dernière en 2023
Janssen
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Cell death & disease   14 février 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
Therapeutic advances in medical oncology   18 janvier 2024
Prior immune checkpoint inhibitor (ICI) therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases   27 novembre 2023
SAFIR 03: A ctDNA Screening Program in Patients With HR+, HER2- Metastatic Breast Cancer for Detection of High-risk Relapse Patients on Any CDK4/6 Inhibitor and a Randomised Phase II Study Comparing Alpelisib Combined With Fulvestrant to Ribociclib Combined With Fulvestrant, in Patients With Persistent Targetable PIK3CA Mutations
Essai Clinique (Unicancer)   20 novembre 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ medicine   27 octobre 2023
TAPAZ: A Randomized Phase II Study of Pazopanib and Weekly Paclitaxel in Patients With Platinum Resistant/Refractory Ovarian Cancer Who Relapse During Bevacizumab Maintenance
Essai Clinique (Novartis)   05 septembre 2023
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
Journal for immunotherapy of cancer   02 décembre 2022
237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
Abstract Book of the ESMO Immuno-Oncology Congress 2022 7-9 December 2022   01 décembre 2022
Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   22 octobre 2022
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Gynecologic oncology   26 juillet 2022